To Investigate the Correlation of Stroke Patients and Demoralized
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03829397 |
|
Recruitment Status :
Completed
First Posted : February 4, 2019
Last Update Posted : March 31, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Post-stroke Depression | Diagnostic Test: Questionnaire |
| Study Type : | Observational |
| Actual Enrollment : | 40 participants |
| Observational Model: | Case-Only |
| Time Perspective: | Other |
| Official Title: | To Investigate the Correlation of Stroke Patients and Demoralized |
| Actual Study Start Date : | February 18, 2019 |
| Actual Primary Completion Date : | March 24, 2020 |
| Actual Study Completion Date : | March 24, 2020 |
- Diagnostic Test: Questionnaire
Questionnaire
- demoralization Scale-Mandarin Version (DS-MV) total score [ Time Frame: through study completion, an average of 1 year ]When participants was included, investigators get on one-time assessment use the demoralization Scale-Mandarin Version (DS-MV). The demoralization Scale-Mandarin Version (DS-MV) minimum score are 0, and maximum score are 96, cut-off point are 30. No subscale.
- demoralization Scale-Mandarin Version (DS-MV) total score split-half reliability [ Time Frame: through study completion, an average of 1 year ]Divide the demoralization Scale-Mandarin Version (DS-MV) into half, and then test the items of the previous half (item 1-12) and the second half (item 13-24) of the questionnaire. Then the two half questionnaire scores were test of correlation coefficient.Then If the degree of correlation is high, the reliability is very high.
- Patient Health Questionnaire (PHQ-9) total score [ Time Frame: through study completion, an average of 1 year ]When participants was included, investigators get on one-time assessment use the Patient Health Questionnaire (PHQ-9) .Patient Health Questionnaire (PHQ-9) minimum score are 0, and maximum score are 27. No subscale.
- demoralization Scale-Mandarin Version (DS-MV) total score criterion-related validity [ Time Frame: through study completion, an average of 1 year ]Correlation test between demoralization Scale-Mandarin Version (DS-MV) total score and Patient Health Questionnaire(PHQ-9) total score.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 100 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Inpatient and outpatient of rehabilitation department in Taoyuan General Hospital, patients diagnosis : who have an infarct stroke or hemorrhagic stroke within three years.
Exclusion Criteria:
- Conscious state confusion, the MMSE score less than 24.
- Unable to understand information, speech disorders, dementia, aphasia.
- The diagnosis of mental illness or mental disorder has been recorded on the medical history.
- The patient or family unwilling to sign an informed consent.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03829397
| Taiwan | |
| Tao-Yuan General Hospital | |
| Taoyuan City, Zhongshan Rd., Taoyuan Dist, Taiwan, No. 1492 | |
Other Publications:
| Responsible Party: | Taoyuan General Hospital |
| ClinicalTrials.gov Identifier: | NCT03829397 |
| Other Study ID Numbers: |
TYGH107037 |
| First Posted: | February 4, 2019 Key Record Dates |
| Last Update Posted: | March 31, 2020 |
| Last Verified: | May 2019 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Demoralization Scale-Mandarin Version Demoralization syndrome |
|
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |

